Table 8 Summary of analysis of adverse events (AEs) in all subjects
Study group | ||
|---|---|---|
Placebo (n = 30) | Meratrim (n = 30) | |
Severity | ||
Mild | 9 | 7 |
Moderate | 0 | 0 |
Severe | 0 | 0 |
Relationship to Test Article | ||
Not related | 9 | 7 |
Possible | 0 | 0 |
Definite | 0 | 0 |
Body System and AEs | ||
Gastrointestinal | ||
Acidity | 0 | 2 |
Dyspepsia | 2 | 3 |
Nausea | 1 | 1 |
Gastritis | 1 | 1 |
Pain | ||
Headache | 1 | 0 |
Dermatology | ||
Itching | 1 | 0 |
Rash on forearm | 1 | 0 |
Neurology | ||
Giddiness | 1 | 0 |
Circulatory | ||
Feet swelling | 1 | 0 |
Total Number of Adverse Events Experienced During Study | 9 | 7 |
Total Number of Subjects Experiencing Adverse Events: n (%) | 6/30 (20 %) | 5/30 (17 %) |